Juliane Ray
General Manager, Commercial
Juliane Ray is the Global Head of Medtech Strategy at Clarivate. In this role, she connects people with intelligence, expertise and workflow tools to bring commercially successful treatments to patients faster and enable teams to make decisions with speed and confidence, from strategy through research and development and, ultimately, commercial execution.
Juliane has held several global leadership roles in the medical device and technology industries. She began her career in consulting at Deloitte and ZS Associates, where she collaborated with life sciences executives on commercial strategy. She spent more than 10 years leading marketing, strategy and operations teams at Cardiovascular Systems Inc (acquired by Abbott Vascular), American Medical Systems (acquired by Boson Scientific) and Landauer (acquired by Danaher) before joining Veeva as Vice President of Medtech Commercial Strategy in 2021 and joining Clarivate in 2024.
Juliane holds an MBA from the University of Virginia (Darden School of Business) and a BA in economics and international studies from Macalester College. She also serves as Board Chair at the Jungle, a nonprofit theater in her home city of Minneapolis, Minnesota.
Latest news
Clarivate Selected by University of Texas at Dallas Libraries to Provide Alma Specto
Alma Specto, an AI-native digital collection and exhibition platform offers UT Dallas Libraries a scalable, flexible and future-ready solution, expanding the reach of its Special Collections to new audiences London,…
Clarivate Reveals the AI50 – the Organizations Leading Artificial Intelligence Invention
London, U.K. March, 26, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Clarivate AI50, a new data-driven benchmark of organizations demonstrating exceptional leadership in…
Annual Report to Identify 189 Global Engineering Fronts Released by Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China
A comprehensive outlook on engineering innovations London, U.K. March 25, 2026. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, the Chinese Academy of Engineering (CAE) and the…